4
Changes in Ownership
Kura Oncology, Inc. Filed Acc 0001209191-20-050590
President and CEO sold 116,901 shares at an average $28.69 ($3,354,384)
- President and CEO acquired 17,926 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
WILSON TROY EDWARD · President and CEO
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-09-11 | Exercise or conversion : show line 1 in the form | +17,926 | $6.15 | $110,245 | 46,022 | D |
| 2020-09-11 | Sale : show line 2 in the form | −17,926 | $28.00 | $501,928 | 28,096 | D |
| 2020-09-11 | Sale : show line 3 in the form | −485 | $28.00 | $13,580 | 305,226 | I |
| 2020-09-14 | Sale : show line 4 in the form | −98,490 | $28.82 | $2,838,876 | 206,736 | I |
| Open-market sales · 116,901 sh · avg $28.69 · $3,354,384 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2020-09-11 | Exercise or conversion : show line 5 in the form Option to purchase common stock | −17,926 | $6.15 | 2027-01-22 | 17,926 | 157,021 | D |
Loading xslF345X03/doc4.xml…